Patents Assigned to Novartis Animal Health US Inc.
  • Patent number: 6673820
    Abstract: The invention relates to novel compounds of the general formula: in which R1 is hydrogen, halogen, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkyl or unsubstituted or mono- to pentasubstituted phenyl, where the substituents are selected from the group consisting of C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, aryloxy, halogen, cyano and nitro, where, if the number of substituents exceeds 1, the substituents can be identical or different; R2 is hydrogen, C1-C6alkyl, (C1-C6alkylene)phenyl, pyridyl, COOR6, CONR7R8, COR6, allyl or CH2—O—R6; R3 is unsubstituted or substituted heterocyclyl, where the substituents are in each case selected from the group consisting of unsubstituted or substituted phenyl, where the substituents are selected from the group consisting of C1-C6alkyl, C1-C6alkoxy, halogen, cyano and nitro, where, if the number of substituents exceeds 1, the substituents can be identical or different, benzyl, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, aryloxy, halogen, cyano, hydroxyl, ami
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: January 6, 2004
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Jacques Bouvier, Maurizio Schwarzenbach
  • Patent number: 6667326
    Abstract: The invention relates to compounds of the general formula wherein R1, R2, R3, R4, R5, X1, X2, X3, m and n have the significances given in claim 1, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for the control of pests on domestic and farm animals.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: December 23, 2003
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Jacques Bouvier, Urs Müller
  • Patent number: 6620767
    Abstract: The invention relates to compounds of the general formula wherein R1 is hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-haloalkyl or unsubstituted or mono- to penta-substituted phenyl, whereby the substituents are selected from the group comprising C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, aryloxy, halogen, cyano and nitro, whereby if the number of substituents is greater than 1, the substituents may be identical or different; R2 is hydrogen, C1-C6-alkyl, (C1-C6-alkylene)phenyl, pyridyl, COOR6, CONR7R8COR6, allyl or CH2—O—R6; R3 is C1-C6-alkyl; R4 is unsubstituted or substituted phenyl, unsubstituted or substituted benzyl or unsubstituted or substituted heterocyclyl, whereby each of the substituents, independently of each other, is selected from the group comprising C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, aryloxy, halogen, cyano, hydroxy, amino and nitro, whereby if the number of substituents is greater than 1, the substituents may be identical or different; R6 is C1-C6
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: September 16, 2003
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Jacques Bouvier
  • Patent number: 6538031
    Abstract: A method of successfully controlling sea lice in commercial fish farming, in an efficient and environmentally friendly way, with the compounds named in claim 1, preferably by injection, and a method of automating this type of control, are described.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: March 25, 2003
    Assignee: Novartis Animal Health US, Inc.
    Inventor: Hariolf Schmid
  • Patent number: 6538013
    Abstract: Novel pesticides of formula (I) wherein the substituents R, R1, R2, R2′, T, U, X and Y are as defined in claim 1, are described. Also described are compositions suitable for use as parasiticides comprising those compounds as active ingredient and to methods of controlling parasites that are based on the administration of those compounds or compositions, and to the use of the said compounds and compositions in a method of controlling parasites and in the manufacture of pesticides for use against parasites. Also described are intermediates of formula (XX) wherein R1, R2, R2′, T, U, X and Y are as defined in claim 1 and Hal is halogen. The latter also exhibit parasiticidal activity and are suitable for the preparation of the compounds of formula (I).
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: March 25, 2003
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Thomas Goebel, Eliane Humbert-Droz, Maurizio Schwarzenbach
  • Patent number: 6410578
    Abstract: The present invention discloses a method for repelling insects, mites and ticks from warm-blooded animals with a benzazole compound.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: June 25, 2002
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Jacques Bouvier, Catherine Christinaz, Olivier Froelich
  • Patent number: 6255316
    Abstract: The present invention relates to several new, polymorphous crystal forms of Dicyclanil, and hydrates and solvates thereof, as well as the preparation thereof. In particular, the invention relates to substantially pure crystal forms of Dicyclanil, having characteristic lattice structures, which are effective for the control of insects and ectoparasites.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: July 3, 2001
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Erwin Marti, Walter Oechslein, André Joseph Geoffroy
  • Patent number: 6201012
    Abstract: The present invention relates to a composition for controlling parasites, in and on animals, which comprises, as active ingredient, a combination, in variable proportions, of at least one parasiticidally active compound, in free form or in salt form, selected from the N-phenyl-N′-benzoyl-urea class of substances, and at least one parasiticidally active compound, in free form or in salt form, selected from the milbemycin, avermectin, milbemycin oxime, moxidectin, ivermectin, abamectin and doramectin classes of substances and the derivatives thereof; to a method of controlling these pests; to a process for the preparation of this composition; and to the use of this composition.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: March 13, 2001
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Philip Anthony Lowndes, Stefan Kemmethmüller, Steven Craig Parks, Douglas Irvin Hepler
  • Patent number: 6110971
    Abstract: The present invention provides a pharmaceutical or veterinary composition comprising, a carrier and an active ingredient being a compound of the following formula I: ##STR1## wherein R.sup.1 and R.sup.2 are each independently hydrogen, halogen or methoxy, as well as salts of the compound of formula I.Further provided by the invention is a method of treatment of fungal infection, comprising administering to a patient in need, an effective amount of the compound of said formula I.
    Type: Grant
    Filed: February 4, 1999
    Date of Patent: August 29, 2000
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Yair Ben-Ziony, Boaz Arzi
  • Patent number: 5994395
    Abstract: The present invention relates to a composition for controlling parasites, in and on animals, which comprises, as active ingredient, a combination, in variable proportions, of at least one parasiticidally active compound, in free form or in salt form, selected from the N-phenyl-N'-benzoyl-urea class of substances, and at least one parasiticidally active compound, in free form or in salt form, selected from the milbemycin, avermectin, milbemycin oxime, moxidectin, ivermectin, abamectin and doramectin classes of substances; to a method of controlling these parasites; to a process for the preparation of this composition; and to the use of this composition.
    Type: Grant
    Filed: January 23, 1998
    Date of Patent: November 30, 1999
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Philip Anthony Lowndes, Stefan Kemmethmuller, Steven Craig Parks, Douglas Irvin Hepler